Strong medicine for Perry in China

Mon Mar 3, 2008



By Pete Gallo

No, it hasn't been a promising season for investors in medical stocks. That is unless you are talking about Perry Capital and its growing portfolio of med stocks in the Far East. Mind you, Perry isn't just dabbling in the sector. In some instances, it's a dominant player. Filings with the Securities and Exchange Commission show that as of early February, Perry was the largest investor in China Medical Technologies, a stock that has exploded in value over the past year.

Perry holds roughly a 12% stake in China Medical, some 3.3 million shares, based on February 14 filings with the SEC. That's good news for Perry, as the stock has jumped from $21 a share to $54 over the past six months. About $10 of that gain came in January and early February, increasing Perry's stake to $178.2 million - a profit of...

ISSN: 2151-1845 / CDC10004H

Register

By registering you will receive

  • A monthly newsletter on your specified areas of interest
  • A fortnightly update on the sector

Free Trial

Take a trial today and access

  • Performance news, fund launches, regulation changes and people moves
  • Profiles of fund managers, investors and distributors
  • Live league tables
  • Investor mandates


Popular Searches on HFI